Why Argentina, Brazil, Chile, Mexico and Colombia.
In Argentina shorter timelines and simpler procedure for post market studies.
Agencies that actively oversee the conduct of research through Inspections, generating a compliance culture.
Brazil and Mexico are the biggest health products market in Latin America, followed by Argentina.
In Chile simpler process in general for Regulatory set up of studies, specifically for medical device research.
Highly professional sites, and attractive timelines for Agency evaluation in Colombia.
In all countries but Brazil, Spanish as a first language which helps synergize translation efforts.
Ample room for growth in Latin America.
Very good retention rates due to strong patient physician relationship.
High quality of professionals, bilingual and many times trained abroad and aware of the best practices and ICH standards.
Good evidence of abundant quality data production for EMA and FDA submissions.